Related Experiment Video
Updated: Mar 25, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer
Verena Ziegler1, Anne Albers1, Gerhard Fritz1
1Institute of Toxicology, Medical Faculty of the Heinrich Heine University Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf, Germany.
Background:
Oral mucositis (OM) is a relevant adverse effect of anticancer therapy involving ionizing radiation (IR) and doxorubicin (Doxo). Because DNA damage of keratinocytes is causative for the pathogenesis of OM, we aim to identify pharmacological measures for geno- and cytoprotection of keratinocytes.
Methods:
We investigated the influence of the lipid-lowering drug lovastatin on cell death, proliferation and DNA damage response (DDR) mechanisms of human keratinocytes following treatment with IR and Doxo.
Results:
Lovastatin protected keratinocytes from the cytotoxic and genotoxic effects of IR and Doxo as shown by a diminished induction of apoptosis as well as a reduced formation and slightly improved repair of DNA damage following Doxo and IR treatment, respectively. Lovastatin selectively blocked the activation of Chk1 and ATR kinases following treatment with IR, Doxo and the ribonucleotide reductase inhibitor hydroxyurea, indicating that the statin antagonizes ATR/Chk1-regulated replicative stress responses. Part of the cytoprotective activity of lovastatin seems to rest on a delayed entry of lovastatin treated cells into S-phase. Yet, because the statin also protected non-proliferating keratinocytes from IR- and Doxo-induced cytotoxicity, cell cycle independent protective mechanisms are involved, too.
Conclusions:
Lovastatin attenuates pro-toxic DNA damage-related responses of keratinocytes stimulated by OM-inducing anticancer therapeutics. The data encourage forthcoming in vivo and clinical studies addressing the usefulness of statins in the prevention of OM.
Insights
Lovastatin protects skin cells from DNA damage caused by cancer therapies like radiation and doxorubicin. This finding suggests statins may help prevent oral mucositis, a common side effect.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Oral mucositis (OM) is a severe side effect of cancer treatments like ionizing radiation (IR) and doxorubicin (Doxo).
- DNA damage in keratinocytes is a key factor in OM development.
- Identifying protective agents for keratinocytes is crucial.
Purpose of the Study:
- To investigate the protective effects of lovastatin against IR- and Doxo-induced damage in human keratinocytes.
- To explore lovastatin's impact on cell death, proliferation, and DNA damage response (DDR) pathways.
Main Methods:
- Human keratinocytes were treated with IR and Doxo, with and without lovastatin.
- Assessed cell death, proliferation, and DNA damage markers.
- Investigated the activation of key DDR kinases (ATR, Chk1).
Main Results:
- Lovastatin reduced apoptosis and DNA damage induced by IR and Doxo.
- Lovastatin inhibited ATR/Chk1 kinase activation, suggesting antagonism of replicative stress responses.
- Cytoprotective effects were observed in both proliferating and non-proliferating keratinocytes, indicating multiple mechanisms.
Conclusions:
- Lovastatin demonstrates significant cytoprotective and genoprotective effects on keratinocytes against OM-inducing agents.
- These findings support further research into statins for OM prevention in cancer patients.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Apoptosis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

